License-Out
License Agreement Has Been Entered with Shengshi Rongen Bio-tech
We executed a non-exclusive license agreement with Shengshi Rongen Bio-tech Co., Ltd. (Shanghai, China) for providing their cosmetic product...
License-Out
We executed a non-exclusive license agreement with Shengshi Rongen Bio-tech Co., Ltd. (Shanghai, China) for providing their cosmetic product...
results 111 - 120 of 231
Other
New patent information relates to iPS cell technologies for the month of November 2018 has been updated. Please see Related Patent Info. for...
Other
Our office will be closed for winter holidays from Saturday 29th December 2018 to Sunday 6th January 2019. Please understand that our earlie...
License-In
We released the summary of 2 newly published patent applications from our "Patent Portfolio" as follows. AJ157 Neurotoxicity evaluation mode...
License-Out
iPS Academia Japan, Inc. has entered into a non-exclusive license agreement with NACALAI TESQUE, INC. (Kyoto, Japan) to provide products and...
Other
New patent information relates to iPS cell technologies for the month of October 2018 has been updated. Please see Related Patent Info. for ...
License-In
We released the summary of 1 newly published patent application from our "Patent Portfolio" as follows. AJ145 Method for inducing exon skip...
Event
We attended BIO-Europe2018 in Copenhagen, Denmark from November 5th (Mon.) till November 7th (Fri.), 2018. We very much appreciate many meet...
License-Out
We executed an exclusive worldwide license agreement with aceRNA Technologies Co., Ltd. (Kyoto, Japan) for providing reagents and services f...
License-Out
We executed a worldwide license agreement with Asahi Kasei Corp. (Tokyo, Japan) for the use of iPS cell-derived cartilage for regenerative t...